Clinical trial · Interventional
Patient-Centered Care for the Older Adult With Hematologic Malignancy
NCT02359838CI-TRIAL-00059712completedN/AResults postedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This research study is evaluating if co-management by a geriatrician embedded in the oncology clinic can improve outcomes for frail older adults with blood cancers. A rigorous pre-entry frailty assessment by a trained research assistant will be followed by randomization to geriatrician co-management versus usual care for patients found to be frail or pre-frail.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hematologic Malignancy | Hematopoietic and Lymphoid Cell Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Baseline Geriatric Screening/Assessment | Other | — | UNRESOLVED |
| Geriatrician Co-Management | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- OTHER
- label
- Usual Care
- description
- Frail/pre-frail hematologic oncology patients receive usual care
- interventionNames
- Other: Baseline Geriatric Screening/Assessment
- type
- ACTIVE_COMPARATOR
- label
- Geriatrician Co-Management
- description
- Frail/pre-frail hematologic oncology patients receive co-management by a geriatrician
- interventionNames
- Other: Baseline Geriatric Screening/Assessment
- Other: Geriatrician Co-Management
Primary outcomes (1)
- measure
- Overall Survival
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: * All patients aged 75 and older who present for an initial consultation at the Dana-Farber/Brigham and Women's Cancer Center for hematologic malignancy (transplantation consultation excluded). * Assessed to be pre-frail or frail on formal baseline geriatric assessment. Exclusion Criteria: * Not willing to participate
References
Publications (0)
Data not yet available
No reference posted for this study.